Reaction of the dimers [(Cp*MCl) 2(μ-Cl) 2] (Cp* = η 5-C 5Me 5) with Ph 2PCH 2CH 2NC(NH( p-Tolyl)) 2 ( H 2L ) in the presence of NaSbF 6 affords the chlorido complexes [Cp*MCl(κ 2 N, P- H 2L )][SbF 6] (M = Rh, 1; Ir, 2). Upon treatment with aqueous NaOH, solutions of 1 and 2 yield the corresponding complexes [Cp*M(κ 3 N, N′, P- HL)][SbF 6] (M = Rh, 3; Ir, 4) in which the ligand HL presents a fac κ 3 N, N′, P coordination mode. Treatment of THF solutions of complexes 3 and 4 with hydrogen gas, at room temperature, results in the formation of the metal hydrido-complexes [Cp*MH(κ 2 N, P- H 2L )][SbF 6] (M = Rh, 5; Ir, 6) in which the N( p-Tolyl) group has been protonated. Complexes 3 and 4 react with deuterated water in a reversible fashion resulting in the gradual deuteration of the Cp* group. Heating at 383 K THF/H 2O solutions of the complexes 3 and 4 affords the orthometalated complexes [Cp*M(κ 3 C, N, P- H 2L -H )][SbF 6] [M = Rh, 7; Ir, 8, H 2L -H = Ph 2PCH 2CH 2NC(NH( p-Tolyl))(NH(4-C 6H 3Me))], respectively. At 333 K, complexes 3 and 4 react in THF with methanol, primary alcohols, or 2-propanol giving the metal-hydrido complexes 5 and 6, respectively. The reaction involves the acceptorless dehydrogenation of the alcohols at a relatively low temperature, without the assistance of an external base. The new complexes have been characterized by the usual analytical and spectroscopic methods including the X-ray diffraction determination of the crystal structures of complexes 1– 5, 7, and 8. Notably, the chlorido complexes 1 and 2 crystallize both as enantiopure conglomerates and as racemates. Reaction mechanisms are proposed based on stoichiometric reactions, nuclear magnetic resonance studies, and X-ray crystallography as well as density functional theory calculations.
In solution, masked transition-metal frustrated Lewis pairs (TMFLPs) give rise to the corresponding TMFLP species which activate dihydrogen, water, and alcohols following FLP reaction pathways. When D 2O or alcohols with deuterated OH groups were employed, H/D exchange at the Cp* ligand (involving C(sp 3)−H activation) was observed. C(sp 2)−H bond activation involving orthometalation of the p-Tolyl ring was also observed.